Page last updated: 2024-10-23

atenolol and Secondary Hyperparathyroidism

atenolol has been researched along with Secondary Hyperparathyroidism in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Makdassi, R2
Andrejak, M2
Morinière, P2
Sebert, JL1
Decourt, S1
Guéris, J1
Coevoet, B2
Fournier, A2
Decourcelle, PH1
de Fremont, JF1
Kassouf, J1
Roussel, A1
Gheerbrand, JD1

Other Studies

2 other studies available for atenolol and Secondary Hyperparathyroidism

ArticleYear
Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremia.
    Advances in experimental medicine and biology, 1982, Volume: 151

    Topics: Adult; Aged; Atenolol; Bicarbonates; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Ag

1982
Blockers of beta and H2 receptors and secondary hyperparathyroidism in uraemia.
    Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association, 1981, Volume: 18

    Topics: Adult; Aged; Atenolol; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism, Secondary; Male;

1981